# ORACEA

NDC: 0299-3822
Generic name: DOXYCYCLINE
Labeler / Manufacturer: Galderma Laboratories, L.P.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20100514

FDA application: NDA050805

## Active ingredients

- DOXYCYCLINE: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0299-3822"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0299-3822
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa15c93a-ff4c-447a-8a21-96da506d8997